NLM Logo

VEPA-L protocol MeSH Supplementary Concept Data 2024


MeSH Supplementary
VEPA-L protocol
Unique ID
C121037
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C121037
Registry Number
0
Heading Mapped to
*Antineoplastic Combined Chemotherapy Protocols
Asparaginase
Cyclophosphamide
Doxorubicin
Methotrexate
Prednisolone
Vincristine
Frequency
1
Note
chemotherapy protocol containing the above cpds; used in the treatment of lymphocytic leukemia and lymphoblastic lymphoma
Source
Jpn J Clin Oncol 1999 Jul;29(7):340-8
Date of Entry
1999/10/06
Revision Date
2000/11/30
VEPA-L protocol Preferred
page delivered in 0.005s